IOL Chemicals and Pharmaceuticals Limited — Important, 13-03-2025: Updates

The sub-division of equity shares for IOL Chemicals and Pharmaceuticals has been successfully processed, resulting in the conversion of each share with a face value of ₹10 into five shares with a face value of ₹2 each. The newly issued shares have been credited under the ISIN INE485C01029.

The authorized share capital remains ₹80 crore post-split, while the issued, paid-up, and subscribed capital is ₹58.70 crore, with the total number of shares increasing to 29.35 crore. This strategic move to reduce the face value of shares is expected to improve liquidity in the market and may attract more investors, signaling a positive outlook for the company’s engagement in the equity market.

Shareholders and investors should monitor developments closely as increased liquidity could lead to heightened interest in the stock.